Form 4 · Filed Jun 17, 2026, 09:10 PM UTC
ABOS/Acumen Pharmaceuticals, Inc.
Porter Derrell — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
7 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | M | other | 13,040 | $1 | $13,953 | 48,540 |
| Jun 17, 2026 | S | sell | 13,040 | $2 | $30,318 | 35,500 |
| Jun 17, 2026 | M | other | 13,040 | — | — | 0 |
| Jun 16, 2026 | S | sell | 12,800 | $2 | $29,773 | 35,500 |
| Jun 15, 2026 | M | other | 6,460 | $1 | $6,912 | 54,760 |
| Jun 15, 2026 | M | other | 6,460 | — | — | 13,040 |
| Jun 15, 2026 | S | sell | 6,460 | $2 | $15,149 | 48,300 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-043987